258 related articles for article (PubMed ID: 10819526)
1. Matrix metalloproteinases in remodeling of the normal and neoplastic mammary gland.
Rudolph-Owen LA; Matrisian LM
J Mammary Gland Biol Neoplasia; 1998 Apr; 3(2):177-89. PubMed ID: 10819526
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis.
Blavier L; Lazaryev A; Dorey F; Shackleford GM; DeClerck YA
Cancer Res; 2006 Mar; 66(5):2691-9. PubMed ID: 16510589
[TBL] [Abstract][Full Text] [Related]
3. Expression of stromelysin-1 and TIMP-1 in the involuting mammary gland and in early invasive tumors of the mouse.
Li F; Strange R; Friis RR; Djonov V; Altermatt HJ; Saurer S; Niemann H; Andres AC
Int J Cancer; 1994 Nov; 59(4):560-8. PubMed ID: 7960227
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice.
Ha HY; Moon HB; Nam MS; Lee JW; Ryoo ZY; Lee TH; Lee KK; So BJ; Sato H; Seiki M; Yu DY
Cancer Res; 2001 Feb; 61(3):984-90. PubMed ID: 11221894
[TBL] [Abstract][Full Text] [Related]
5. Mammary involution and breast cancer risk: transgenic models and clinical studies.
Radisky DC; Hartmann LC
J Mammary Gland Biol Neoplasia; 2009 Jun; 14(2):181-91. PubMed ID: 19404726
[TBL] [Abstract][Full Text] [Related]
6. The role of cathepsins in involution and breast cancer.
Watson CJ; Kreuzaler PA
J Mammary Gland Biol Neoplasia; 2009 Jun; 14(2):171-9. PubMed ID: 19437107
[TBL] [Abstract][Full Text] [Related]
7. The caM kinase, Pnck, is spatially and temporally regulated during murine mammary gland development and may identify an epithelial cell subtype involved in breast cancer.
Gardner HP; Ha SI; Reynolds C; Chodosh LA
Cancer Res; 2000 Oct; 60(19):5571-7. PubMed ID: 11034105
[TBL] [Abstract][Full Text] [Related]
8. The role of microRNAs regulating the expression of matrix metalloproteinases (MMPs) in breast cancer development, progression, and metastasis.
Javadian M; Gharibi T; Shekari N; Abdollahpour-Alitappeh M; Mohammadi A; Hossieni A; Mohammadi H; Kazemi T
J Cell Physiol; 2019 May; 234(5):5399-5412. PubMed ID: 30565667
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases and their expression in mammary gland.
Uria JA; Werb Z
Cell Res; 1998 Sep; 8(3):187-94. PubMed ID: 9791732
[TBL] [Abstract][Full Text] [Related]
10. Circadian concepts in normal and neoplastic breast.
Coudert B
Chronobiol Int; 2002 Jan; 19(1):221-35. PubMed ID: 11962678
[TBL] [Abstract][Full Text] [Related]
11. Expression and localization of extracellular matrix-degrading proteinases and their inhibitors in the bovine mammary gland during development, function, and involution.
Rabot A; Sinowatz F; Berisha B; Meyer HH; Schams D
J Dairy Sci; 2007 Feb; 90(2):740-8. PubMed ID: 17235151
[TBL] [Abstract][Full Text] [Related]
12. A mouse mammary gland involution mRNA signature identifies biological pathways potentially associated with breast cancer metastasis.
Stein T; Salomonis N; Nuyten DS; van de Vijver MJ; Gusterson BA
J Mammary Gland Biol Neoplasia; 2009 Jun; 14(2):99-116. PubMed ID: 19408105
[TBL] [Abstract][Full Text] [Related]
13. Expression pattern of four membrane-type matrix metalloproteinases in the normal and diseased mouse mammary gland.
Szabova L; Yamada SS; Birkedal-Hansen H; Holmbeck K
J Cell Physiol; 2005 Oct; 205(1):123-32. PubMed ID: 15895410
[TBL] [Abstract][Full Text] [Related]
14. Aromatase overexpression and breast hyperplasia, an in vivo model--continued overexpression of aromatase is sufficient to maintain hyperplasia without circulating estrogens, and aromatase inhibitors abrogate these preneoplastic changes in mammary glands.
Tekmal RR; Kirma N; Gill K; Fowler K
Endocr Relat Cancer; 1999 Jun; 6(2):307-14. PubMed ID: 10731124
[TBL] [Abstract][Full Text] [Related]
15. Roles of the matrix metalloproteinases in mammary gland development and cancer.
Benaud C; Dickson RB; Thompson EW
Breast Cancer Res Treat; 1998 Jul; 50(2):97-116. PubMed ID: 9822215
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer.
Radisky ES; Radisky DC
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):201-12. PubMed ID: 20440544
[TBL] [Abstract][Full Text] [Related]
17. Bcl-2 gene family and related proteins in mammary gland involution and breast cancer.
Schorr K; Li M; Krajewski S; Reed JC; Furth PA
J Mammary Gland Biol Neoplasia; 1999 Apr; 4(2):153-64. PubMed ID: 10426394
[TBL] [Abstract][Full Text] [Related]
18. The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter.
Sternlicht MD; Bissell MJ; Werb Z
Oncogene; 2000 Feb; 19(8):1102-13. PubMed ID: 10713697
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of aromatase leads to hyperplasia and changes in the expression of genes involved in apoptosis, cell cycle, growth, and tumor suppressor functions in the mammary glands of transgenic mice.
Kirma N; Gill K; Mandava U; Tekmal RR
Cancer Res; 2001 Mar; 61(5):1910-8. PubMed ID: 11280746
[TBL] [Abstract][Full Text] [Related]
20. Stromelysin-3 in the biology of the normal and neoplastic mammary gland.
Rio MC; Lefebvre O; Santavicca M; Noël A; Chenard MP; Anglard P; Byrne JA; Okada A; Régnier CH; Masson R; Bellocq JP; Basset P
J Mammary Gland Biol Neoplasia; 1996 Apr; 1(2):231-40. PubMed ID: 10887496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
